TP53 mutations occur in more than half of human cancers, with colorectal, head and neck, esophagus, female genital organs, and lung cancers exhibiting the highest prevalence (37–43%; International Agency for Research on Cancer (IARC) TP53 Database, R20, July 2019) [31]. This evidence concerns the gene TP53 and lung carcinoma.